Original Article
Author Details :
Volume : 9, Issue : 1, Year : 2022
Article Page : 31-33
https://doi.org/10.18231/j.ijpo.2022.007
Abstract
Background: In developing countries like India, the burden of cervical cancer is still high. According to the World Cancer statistics, >80% of all the cervical cancer cases are found in developing and low-resource countries, because of a lack of awareness. Apart from diagnosing cervical cancers pap test also aids in the diagnosis of inflammatory conditions.
Materials and Methods: This is a retrospective study carried out at A.C.S Medical college and hospital, Chennai during January 2018- to June 2019. Total of 892 pap smears are included in the study. Both endocervix and ectocervix were sampled. Immediately slides were fixed in 95% ethyl alcohol and subsequently stained by PAP and Hand E stains. Stained slides are mounted with DPX and reported by Pathologist according to Bethesda system. The data was collected and analysed statistically.
Results: A total of 892 pap smears are included in the study. Out of which, 701 smears were found to have pathology accounting for 78.5%. 396 smears were found to be inflammatory accounting for 56.4%.ASCUS, AGUS and HSIL were accounting for 11.9%, 9.4% and 2.4% respectively.
Conclusion: We can conclude Pap test is a simple, cost effective tool in the diagnosis of Inflammatory, Premalignant and Malignant lesions of cervix. Awareness and screening programmes have to be done effectively which helps in detection of premalignant lesions and reduce the incidence of cervical cancer.
Keywords: Papsmear, ASCUS, AGUS and HSIL
How to cite : Divya J, Subramanian V, Mahendranath P, Bai S, Pattern of cervical papsmear cytology- Our experience. Indian J Pathol Oncol 2022;9(1):31-33
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 12-10-2021
Accepted : 09-11-2021
Viewed: 970
PDF Downloaded: 701